Selected research
Industry Growth & Trends
Global Chronic Refractory Cough (CRC) Treatment Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Chronic Refractory Cough (CRC) Treatment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Chronic Refractory Cough (CRC) Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Chronic Refractory Cough (CRC) Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Chronic Refractory Cough (CRC) Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Chronic Refractory Cough (CRC) Treatment market include Shionogi, Merck, Respivant Sciences, Nerre Therapeutics, Bellus Health and Attenua, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Chronic Refractory Cough (CRC) Treatment market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Chronic Refractory Cough (CRC) Treatment market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Chronic Refractory Cough (CRC) Treatment market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Chronic Refractory Cough (CRC) Treatment.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Chronic Refractory Cough (CRC) Treatment market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Chronic Refractory Cough (CRC) Treatment Market by Company
Shionogi
Merck
Respivant Sciences
Nerre Therapeutics
Bellus Health
Attenua
Chronic Refractory Cough (CRC) Treatment Segment by Type
Speech Therapy
Physiotherapy
Chronic Refractory Cough (CRC) Treatment Segment by Application
Hospital
Clinic
Others
Chronic Refractory Cough (CRC) Treatment Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Chronic Refractory Cough (CRC) Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Chronic Refractory Cough (CRC) Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Chronic Refractory Cough (CRC) Treatment.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Chronic Refractory Cough (CRC) Treatment companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Speech Therapy
- Physiotherapy
Applications
- Hospital
- Clinic
- Others
Companies covered
- Shionogi
- Merck
- Respivant Sciences
- Nerre Therapeutics
- Bellus Health
- Attenua
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Chronic Refractory Cough (CRC) Treatment Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Chronic Refractory Cough (CRC) Treatment Market Size by Region (2021-2032)
- 1.4.1 Global Chronic Refractory Cough (CRC) Treatment Market Size by Region (2021-2026)
- 1.4.2 Global Chronic Refractory Cough (CRC) Treatment Market Size by Region (2027-2032)
- 1.5 Key Regions Chronic Refractory Cough (CRC) Treatment Market Size (2021-2032)
- 1.5.1 North America Chronic Refractory Cough (CRC) Treatment Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Chronic Refractory Cough (CRC) Treatment Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Chronic Refractory Cough (CRC) Treatment Market Size Growth Rate (2021-2032)
- 1.5.4 South America Chronic Refractory Cough (CRC) Treatment Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Chronic Refractory Cough (CRC) Treatment Market Size Growth Rate (2021-2032)
2 Chronic Refractory Cough (CRC) Treatment Market by Type
- 2.1 Type Introduction
- 2.1.1 Speech Therapy
- 2.1.2 Physiotherapy
- 2.2 Global Chronic Refractory Cough (CRC) Treatment Market Size by Type
- 2.2.1 Global Chronic Refractory Cough (CRC) Treatment Market Size Overview by Type (2021-2032)
- 2.2.2 Global Chronic Refractory Cough (CRC) Treatment Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Chronic Refractory Cough (CRC) Treatment Market Size Forecasted by Type (2027-2032)
- 2.3 Global Chronic Refractory Cough (CRC) Treatment Market Size by Regions
- 2.3.1 North America Chronic Refractory Cough (CRC) Treatment Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Chronic Refractory Cough (CRC) Treatment Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Chronic Refractory Cough (CRC) Treatment Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Chronic Refractory Cough (CRC) Treatment Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Chronic Refractory Cough (CRC) Treatment Market Size Breakdown by Type (2021-2026)
3 Chronic Refractory Cough (CRC) Treatment Market by Application
- 3.1 Type Introduction
- 3.1.1 Hospital
- 3.1.2 Clinic
- 3.1.3 Others
- 3.2 Global Chronic Refractory Cough (CRC) Treatment Market Size by Application
- 3.2.1 Global Chronic Refractory Cough (CRC) Treatment Market Size Overview by Application (2021-2032)
- 3.2.2 Global Chronic Refractory Cough (CRC) Treatment Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Chronic Refractory Cough (CRC) Treatment Market Size Forecasted by Application (2027-2032)
- 3.3 Global Chronic Refractory Cough (CRC) Treatment Market Size by Regions
- 3.3.1 North America Chronic Refractory Cough (CRC) Treatment Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Chronic Refractory Cough (CRC) Treatment Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Chronic Refractory Cough (CRC) Treatment Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Chronic Refractory Cough (CRC) Treatment Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Chronic Refractory Cough (CRC) Treatment Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Chronic Refractory Cough (CRC) Treatment Industry Trends
- 4.2 Chronic Refractory Cough (CRC) Treatment Industry Drivers
- 4.3 Chronic Refractory Cough (CRC) Treatment Industry Opportunities and Challenges
- 4.4 Chronic Refractory Cough (CRC) Treatment Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Chronic Refractory Cough (CRC) Treatment Revenue (2021-2026)
- 5.2 Global Chronic Refractory Cough (CRC) Treatment Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Chronic Refractory Cough (CRC) Treatment Key Company Headquarters & Area Served
- 5.4 Global Chronic Refractory Cough (CRC) Treatment Company, Product Type & Application
- 5.5 Global Chronic Refractory Cough (CRC) Treatment Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Chronic Refractory Cough (CRC) Treatment Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Chronic Refractory Cough (CRC) Treatment Players Market Share by Revenue in 2025
- 5.6.3 2025 Chronic Refractory Cough (CRC) Treatment Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Shionogi
- 6.1.1 Shionogi Company Information
- 6.1.2 Shionogi Business Overview
- 6.1.3 Shionogi Chronic Refractory Cough (CRC) Treatment Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Shionogi Chronic Refractory Cough (CRC) Treatment Product Portfolio
- 6.1.5 Shionogi Recent Developments
- 6.2 Merck
- 6.2.1 Merck Company Information
- 6.2.2 Merck Business Overview
- 6.2.3 Merck Chronic Refractory Cough (CRC) Treatment Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Merck Chronic Refractory Cough (CRC) Treatment Product Portfolio
- 6.2.5 Merck Recent Developments
- 6.3 Respivant Sciences
- 6.3.1 Respivant Sciences Company Information
- 6.3.2 Respivant Sciences Business Overview
- 6.3.3 Respivant Sciences Chronic Refractory Cough (CRC) Treatment Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Respivant Sciences Chronic Refractory Cough (CRC) Treatment Product Portfolio
- 6.3.5 Respivant Sciences Recent Developments
- 6.4 Nerre Therapeutics
- 6.4.1 Nerre Therapeutics Company Information
- 6.4.2 Nerre Therapeutics Business Overview
- 6.4.3 Nerre Therapeutics Chronic Refractory Cough (CRC) Treatment Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Nerre Therapeutics Chronic Refractory Cough (CRC) Treatment Product Portfolio
- 6.4.5 Nerre Therapeutics Recent Developments
- 6.5 Bellus Health
- 6.5.1 Bellus Health Company Information
- 6.5.2 Bellus Health Business Overview
- 6.5.3 Bellus Health Chronic Refractory Cough (CRC) Treatment Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Bellus Health Chronic Refractory Cough (CRC) Treatment Product Portfolio
- 6.5.5 Bellus Health Recent Developments
- 6.6 Attenua
- 6.6.1 Attenua Company Information
- 6.6.2 Attenua Business Overview
- 6.6.3 Attenua Chronic Refractory Cough (CRC) Treatment Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Attenua Chronic Refractory Cough (CRC) Treatment Product Portfolio
- 6.6.5 Attenua Recent Developments
7 North America
- 7.1 North America Chronic Refractory Cough (CRC) Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Chronic Refractory Cough (CRC) Treatment Market Size by Country (2021-2026)
- 7.3 North America Chronic Refractory Cough (CRC) Treatment Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Chronic Refractory Cough (CRC) Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Chronic Refractory Cough (CRC) Treatment Market Size by Country (2021-2026)
- 8.3 Europe Chronic Refractory Cough (CRC) Treatment Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Chronic Refractory Cough (CRC) Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Chronic Refractory Cough (CRC) Treatment Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Chronic Refractory Cough (CRC) Treatment Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Chronic Refractory Cough (CRC) Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Chronic Refractory Cough (CRC) Treatment Market Size by Country (2021-2026)
- 10.3 South America Chronic Refractory Cough (CRC) Treatment Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Chronic Refractory Cough (CRC) Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Chronic Refractory Cough (CRC) Treatment Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Chronic Refractory Cough (CRC) Treatment Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst